1. Home
  2. ORGN vs CRBU Comparison

ORGN vs CRBU Comparison

Compare ORGN & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORGN
  • CRBU
  • Stock Information
  • Founded
  • ORGN 2008
  • CRBU 2011
  • Country
  • ORGN United States
  • CRBU United States
  • Employees
  • ORGN N/A
  • CRBU N/A
  • Industry
  • ORGN Major Chemicals
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • ORGN Industrials
  • CRBU Health Care
  • Exchange
  • ORGN Nasdaq
  • CRBU Nasdaq
  • Market Cap
  • ORGN 96.4M
  • CRBU 93.0M
  • IPO Year
  • ORGN N/A
  • CRBU 2021
  • Fundamental
  • Price
  • ORGN $0.67
  • CRBU $0.77
  • Analyst Decision
  • ORGN Strong Buy
  • CRBU Strong Buy
  • Analyst Count
  • ORGN 1
  • CRBU 5
  • Target Price
  • ORGN $3.00
  • CRBU $10.60
  • AVG Volume (30 Days)
  • ORGN 720.1K
  • CRBU 1.0M
  • Earning Date
  • ORGN 05-15-2025
  • CRBU 05-08-2025
  • Dividend Yield
  • ORGN N/A
  • CRBU N/A
  • EPS Growth
  • ORGN N/A
  • CRBU N/A
  • EPS
  • ORGN N/A
  • CRBU N/A
  • Revenue
  • ORGN $31,282,000.00
  • CRBU $9,918,000.00
  • Revenue This Year
  • ORGN $49.18
  • CRBU N/A
  • Revenue Next Year
  • ORGN $144.81
  • CRBU $163.34
  • P/E Ratio
  • ORGN N/A
  • CRBU N/A
  • Revenue Growth
  • ORGN 8.60
  • CRBU N/A
  • 52 Week Low
  • ORGN $0.42
  • CRBU $0.66
  • 52 Week High
  • ORGN $1.90
  • CRBU $4.21
  • Technical
  • Relative Strength Index (RSI)
  • ORGN 47.17
  • CRBU 43.66
  • Support Level
  • ORGN $0.64
  • CRBU $0.73
  • Resistance Level
  • ORGN $0.71
  • CRBU $0.91
  • Average True Range (ATR)
  • ORGN 0.06
  • CRBU 0.08
  • MACD
  • ORGN 0.00
  • CRBU 0.01
  • Stochastic Oscillator
  • ORGN 16.65
  • CRBU 24.34

About ORGN Origin Materials Inc.

Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: